Ondine Biomedical, Inc. operates as a life sciences company that develops photodisinfection-based therapies to address drug-resistant infections. Its platform technology called antimicrobial photodynamic disinfection to help prevent and help treat infections across many therapeutic areas in healthcare and industry settings. The firm's novel, patented platform technology both reduces inflammation and eliminates harmful pathogens, rapidly destroying bacteria, fungi and viruses including superbugs and SARS-CoV-2. The company was founded by Carolyn Cross on September 9, 1996 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Ondine Biomedical Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Ondine Biomedical Inc market cap is $72.57M.
What is the 52-week high for Ondine Biomedical Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ondine Biomedical Inc 52 week high is $0.14 as of October 01, 2025.
What is the 52-week low for Ondine Biomedical Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ondine Biomedical Inc 52 week low is $0.11 as of October 01, 2025.
What is Ondine Biomedical Inc stock price today?
Ondine Biomedical Inc stock price today is $0.14.
What was Ondine Biomedical Inc stock price yesterday?
Ondine Biomedical Inc stock price yesterday was $0.14.
What is the PE ratio of Ondine Biomedical Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Ondine Biomedical Inc’s P/E ratio is -2.76.
What is the Price-to-Book ratio of Ondine Biomedical Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Ondine Biomedical Inc P/B ratio is 11.8243.
What is the 50-day moving average of Ondine Biomedical Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Ondine Biomedical Inc 50-day moving average is $0.14.
